GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹5,218 Cr | ₹4,247 Cr | ₹6,172 Cr | ₹5,270 Cr | ₹4,611 Cr |
What is the latest Net Current Assets ratio of GLAND PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹5,218 Cr |
| Mar2024 | ₹4,247 Cr |
| Mar2023 | ₹6,172 Cr |
| Mar2022 | ₹5,270 Cr |
| Mar2021 | ₹4,611 Cr |
How is Net Current Assets of GLAND PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,218 Cr | 22.87 | |
| Mar2024 | ₹4,247 Cr | -31.19 | |
| Mar2023 | ₹6,172 Cr | 17.11 | |
| Mar2022 | ₹5,270 Cr | 14.29 | |
| Mar2021 | ₹4,611 Cr | - | |
Compare Net Current Assets of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹27,829.8 Cr | -0.4% | 2.1% | 2.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -0.4% |
2.1% |
2.7% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses